• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组DNA甲基化分析表明,热消融治疗乙型肝炎病毒相关肝细胞癌后存在免疫反应。

Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV-associated hepatocellular carcinoma.

作者信息

Zhao Yanan, Li Kang, Sun Jianping, He Ning, Zhao Peng, Zang Chaoran, Yang Xiaozhen, Hu Caixia, Long Jiang, Zhang Honghai, Wang Qi, Zhao Yan, Zhang Yonghong

机构信息

Research Center for Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing 100069, P.R. China.

Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, P.R. China.

出版信息

Oncol Lett. 2020 Jul;20(1):677-684. doi: 10.3892/ol.2020.11636. Epub 2020 May 18.

DOI:10.3892/ol.2020.11636
PMID:32565992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7285841/
Abstract

Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is the most common type of liver cancer in China. Thermal ablation is one of the main strategies for HCC treatment. However, few studies have investigated the properties of the immune response following thermal ablation thus far. In the present study, five subjects with HBV-associated HCC were recruited from The Beijing Youan Hospital. Peripheral blood mononuclear cells (PBMCs) were collected at three time points: Prior to thermal ablation (PR), 1-3 days post-ablation (P1) and 5-7 days post-ablation (P7). An Illumina 850K methylation microarray was employed to determine the DNA methylation profile of each sample. Data were analyzed using different methylation probes with the Bioconductor package in R. Following annotation of different methylation CG sites (CGs), the associated genes were subjected to an Ingenuity Pathway Analysis. A total of 3,000 significantly different CGs (adjusted P<0.05; |log(fold-change)|>0.5) were identified within the PR, P1 and P7 time points. Of these, 744 (24.8%) sites increased between the PR and P1 time points but gradually decreased at the P7 time point. The remaining 2,256 (75.2%) sites decreased between the PR and P1 time points gradually increased at the P7 time point. Following gene annotation of different CGs on the promoter, signaling pathways analysis demonstrated that 'p70S6K signaling', 'CXCR4 signaling', 'dendritic cell maturation', 'production of nitric oxide and reactive oxygen species in macrophages' pathways were activated at the P7 time point. The present study suggested that PBMC DNA methylation had changed soon after thermal ablation for subjects with HBV-associated HCC, and systemic immune responses were activated, particularly at the P7 time point.

摘要

乙型肝炎病毒(HBV)相关肝细胞癌(HCC)是中国最常见的肝癌类型。热消融是肝癌治疗的主要策略之一。然而,迄今为止,很少有研究调查热消融后免疫反应的特性。在本研究中,从北京佑安医院招募了5名HBV相关HCC患者。在三个时间点采集外周血单个核细胞(PBMC):热消融前(PR)、消融后1 - 3天(P1)和消融后5 - 7天(P7)。采用Illumina 850K甲基化微阵列来确定每个样本的DNA甲基化谱。使用R语言中的Bioconductor软件包对不同的甲基化探针进行数据分析。在对不同的甲基化CG位点(CGs)进行注释后,对相关基因进行了Ingenuity通路分析。在PR、P1和P7时间点共鉴定出3000个显著不同的CGs(校正P<0.05;|log(倍数变化)|>0.5)。其中,744个(24.8%)位点在PR和P1时间点之间增加,但在P7时间点逐渐减少。其余2256个(75.2%)位点在PR和P1时间点之间减少,在P7时间点逐渐增加。在对启动子上不同CGs进行基因注释后,信号通路分析表明,“p70S6K信号通路”、“CXCR4信号通路”、“树突状细胞成熟”、“巨噬细胞中一氧化氮和活性氧的产生”通路在P7时间点被激活。本研究表明,对于HBV相关HCC患者,热消融后PBMC DNA甲基化很快发生变化,全身免疫反应被激活,特别是在P7时间点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd0/7285841/32a472698d70/ol-20-01-0677-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd0/7285841/32a472698d70/ol-20-01-0677-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd0/7285841/32a472698d70/ol-20-01-0677-g01.jpg

相似文献

1
Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV-associated hepatocellular carcinoma.基因组DNA甲基化分析表明,热消融治疗乙型肝炎病毒相关肝细胞癌后存在免疫反应。
Oncol Lett. 2020 Jul;20(1):677-684. doi: 10.3892/ol.2020.11636. Epub 2020 May 18.
2
Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.全基因组鉴定与乙肝携带者早发性肝细胞癌发生相关的血液DNA甲基化模式
Mol Carcinog. 2017 Feb;56(2):425-435. doi: 10.1002/mc.22505. Epub 2016 Jun 10.
3
Hepatitis virus infection affects DNA methylation in mice with humanized livers.肝炎病毒感染影响人源化肝脏小鼠的 DNA 甲基化。
Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30.
4
Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关性肝细胞癌中细胞周期蛋白D1启动子的低甲基化
Medicine (Baltimore). 2020 May;99(20):e20326. doi: 10.1097/MD.0000000000020326.
5
Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.基于病毒状态的肝细胞癌全基因组DNA甲基化图谱比较
Epigenetics. 2016 Jun 2;11(6):464-74. doi: 10.1080/15592294.2016.1151586. Epub 2016 Jun 1.
6
Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.乙型肝炎病毒感染中 Exportin 4 基因表达和 DNA 启动子甲基化状态。
J Viral Hepat. 2014 Apr;21(4):241-50. doi: 10.1111/jvh.12136. Epub 2013 Jul 24.
7
Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.乙型肝炎病毒相关肝细胞癌(HCC)患者氧化应激增加及RUNX3高甲基化,以及活性氧在肝癌细胞中诱导RUNX3高甲基化
Asian Pac J Cancer Prev. 2015;16(13):5343-8. doi: 10.7314/apjcp.2015.16.13.5343.
8
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.HBV 诱导感染和肝细胞癌中的 microRNA 谱。
BMC Cancer. 2017 Dec 1;17(1):805. doi: 10.1186/s12885-017-3816-1.
9
[Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].雄激素受体表达与乙型肝炎病毒X蛋白的相关性及其在肝细胞癌中的临床意义
Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):282-7. doi: 10.3760/cma.j.issn.0253-3766.2013.04.009.
10
Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.慢性乙型肝炎患者体内的调节性 T 细胞通过抑制抗肿瘤免疫反应来影响肝细胞癌的免疫发病机制。
J Viral Hepat. 2010 Mar;17 Suppl 1:34-43. doi: 10.1111/j.1365-2893.2010.01269.x.

引用本文的文献

1
Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma.免疫检查点抑制剂与局部区域治疗联合用于肝细胞癌的治疗
Cancers (Basel). 2023 Oct 20;15(20):5072. doi: 10.3390/cancers15205072.
2
Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy.PD-1 抑制剂预防介入治疗后肝细胞癌复发的疗效和安全性的初步观察。
Front Immunol. 2022 Oct 28;13:1019772. doi: 10.3389/fimmu.2022.1019772. eCollection 2022.
3
Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma.

本文引用的文献

1
Radiotherapy activates autophagy to increase CD8 T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer.放射疗法通过调节非小细胞肺癌中主要组织相容性复合体I类的表达来激活自噬,以增加CD8 T细胞浸润。
J Int Med Res. 2019 Aug;47(8):3818-3830. doi: 10.1177/0300060519855595. Epub 2019 Jun 12.
2
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?中国当前癌症形势:2018 年全球癌症统计数据带来的是好消息还是坏消息?
Cancer Commun (Lond). 2019 Apr 29;39(1):22. doi: 10.1186/s40880-019-0368-6.
3
Countdown to 2030: eliminating hepatitis B disease, China.
联合DNA甲基化和转录组评估以确定PD-1阴性肝细胞癌的预后模型
Front Cell Dev Biol. 2021 Aug 11;9:708819. doi: 10.3389/fcell.2021.708819. eCollection 2021.
倒计时 2030:消除乙型肝炎疾病,中国。
Bull World Health Organ. 2019 Mar 1;97(3):230-238. doi: 10.2471/BLT.18.219469. Epub 2019 Jan 28.
4
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization.经动脉化疗栓塞治疗后,炎症细胞因子和 Th1/Th2 平衡变化可作为预测肝细胞癌患者预后的指标。
Sci Rep. 2019 Mar 1;9(1):3260. doi: 10.1038/s41598-019-40078-8.
5
Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].《欧洲肝脏研究学会临床实践指南:肝细胞癌的管理》勘误[《肝脏病学杂志》69(2018)182 - 236]
J Hepatol. 2019 Apr;70(4):817. doi: 10.1016/j.jhep.2019.01.020. Epub 2019 Feb 7.
6
Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer.CXCR4 靶向在癌症放化疗和免疫治疗中的潜在作用。
Front Immunol. 2018 Dec 21;9:3018. doi: 10.3389/fimmu.2018.03018. eCollection 2018.
7
Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children.微波消融联合经动脉化疗栓塞术治疗婴幼儿及儿童不可切除的肝母细胞瘤有效。
Medicine (Baltimore). 2018 Oct;97(42):e12607. doi: 10.1097/MD.0000000000012607.
8
Incomplete radiofrequency ablation promotes the development of CD133 cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression.不完全射频消融通过诱导 SOX9 表达促进肝癌细胞系 HepG2 中 CD133 癌症干细胞的发展。
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):416-422. doi: 10.1016/j.hbpd.2018.09.012. Epub 2018 Sep 15.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.射频消融联合经导管动脉化疗栓塞与手术切除治疗米兰标准范围内肝细胞癌的疗效比较:一项荟萃分析。
Korean J Radiol. 2018 Jul-Aug;19(4):613-622. doi: 10.3348/kjr.2018.19.4.613. Epub 2018 Jun 14.